BiotechTube
Home/Selagine/Michael T. Flavin, PhD
MT

Michael T. Flavin, PhD

CMC Advisor

Selagine

Therapeutic Areas

OphthalmologyOcular Surface Disease

Selagine Pipeline

DrugIndicationPhase
SLG-100Dry Eye Disease (DED)Clinical Stage (Pilot trial completed)
SLG-200Bacterial Keratitis / Infectious KeratitisPre-clinical

Leadership Team at Selagine

DS
Dr. Sandeep Jain, MD, FARVO
Founder & President
SK
Simon Kaja, PhD
Pre-Clinical Advisor
YD
Yogita Desai, PhD
Regulatory Advisor
IS
Iram Shah, MBA
Business Advisor
View full Selagine profile